This video presentation is the fourth of the 5 part video created by ZMDI for the introduction of its leading-edge DrMOS family. In this video, the presenter focused on discussing some of the ...
Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma: DREAMM-14. Background: Elranatamab ...
3 Department of Pediatrics, Hospital for Sick Children, Toronto, Canada 4 Department of Pediatrics, Children’s Hospital of Eastern, Ontario, University of Ottawa, Ottawa, Canada 5 Department of ...
A once-weekly, 2.4-mg dose of subcutaneous semaglutide, a glucagon-like peptide-1 receptor agonist, is used to treat obesity in adults, but assessment of the drug in adolescents has been lacking. In ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results